Why use Research Partnership
We asked our clients to describe us and they said we are intelligent, trusted and customer-led
Our 130+ researchers led by a strong senior team of over 30 Directors and Associate Directors manage over 250 global projects in over 60 countries a year.
We answer the research objectives, but we also aim to go beyond this to help address the fundamental business question.
Because we are independent we can be truly flexible, which means we work on our clients' terms to meet their needs.
*2015-16 Project feedback survey
Our people »
“Your results have driven key decision making which is now translating into very good performance for our brand, so well done”Commercial Analysis Manager
“I would like to thank all of you for the excellent work you did and all the support provided. Your expertise and professionalism was highly appreciated, as were the provided results. I’m already looking forward to the next possibility to work with you.”International Business Analyst
“Working on large-scale quantitative studies with the team at the Research Partnership over the last 4 years has been a positive collaboration. They have been excellent to work with and have helped set out realistic expectations for research projects, asking insightful questions during the setup process, giving guidance to sampling and quotas and also mapping timelines to ensure that the work meets company objectives. The team's experience in managing large and multi-market quant studies, and also their responsive attitude, has been a major factor contributing to the success of projects. It is always a pleasure working with RP team on quantitative studies.”Associate Director, Global Business Intelligence
“I just want to thank you for the recent project you ran very successfully. The report delivered was high quality, definitely bringing new insights and ways to look at our marketing issue. It was also clear at the presentation that you had a deep understanding of the disease area. Very good job!”Director, Business Analysis
- Some example case studiesHow we used behavioural economic theory to reveal fresh insights into patient compliance
Our client currently has a product for a chronic rare disease which has seen an initial successful uptake. HCPs appear to support the product and are actively prescribing it to suitable patients.read more »How we assessed the access potential of a new product in order to develop a successful launch strategy
Our client had two regimens in clinical development for the front-line treatment of an oncology condition using a breakthrough product; and planned to release outcomes data at key industry events throughout the year.read more »How we facilitated mock negotiations with payers to improve the pricing strategy for a new biologic in Latin America
Our client wanted to understand how they should manage payer objections within the value proposition, clinical evidence and economic value of the product.read more »